Wearing-off At The End Of Natalizumab Dosing Intervals Is Associated With Low Receptor Occupancy
Neurology, Neuroimmunology & Neuroinflammation | February 04, 2020 Bringeland GH, Blaser N, Myhr KM, Vedeler CA and Gavasso S Neurol Neuroimmunol Neuroinflamm 2020;7:e678. DOI: https://doi.org/10.1212/NXI.0000000000000678 Abstract Objective We aimed to investigate whether wearing-off…
read more